Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling

BioSystems

Volumn 134, Issue , 2015, Pages 1-15

  Liang, Jingyi ^a   Kulasiri, Don ^a   Samarasinghe, Sandhya ^a  

^a LINCOLN UNIVERSITY   (New Zealand)

Author keywords

Alzheimer's disease; Amyloid ; Ca2+ dysregulation; Computational modeling; Endoplasmic reticulum; Systems biology

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM CHANNEL; CALCIUM ION; GAMMA SECRETASE; PRESENILIN; CALCIUM;

CALCIUM; CELL ORGANELLE; COMPUTER SIMULATION; CYTOLOGY; GENE; HOMEOSTASIS; MUTATION; NERVOUS SYSTEM DISORDER; PROTEIN;

ALZHEIMER DISEASE; BRAIN NERVE CELL; CALCIUM HOMEOSTASIS; CALCIUM ION DYSREGULATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; DIFFUSION; ENDOPLASMIC RETICULUM; GENE MUTATION; HUMAN; INTRACELLULAR SIGNALING; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; NERVOUS SYSTEM FUNCTION; NONHUMAN; REVIEW; BIOLOGY; GENETICS; HOMEOSTASIS; METABOLISM;

ALZHEIMER DISEASE; CALCIUM; CALCIUM SIGNALING; COMPUTATIONAL BIOLOGY; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMANS; PRESENILINS;

EID: 84930198272     PISSN: 03032647     EISSN: 18728324     Source Type: Journal    
DOI: 10.1016/j.biosystems.2015.05.003     Document Type: Review

References (191)

1. Adasme T., Haeger P., Paula-Lima A.C., Espinoza I., Casas-Alarcón M.M., Carrasco M.A., Hidalgo C. Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proc. Natl. Acad. Sci. 2011, 108:3029-3034.
2. 3R-dependent and -independent mechanisms. Front. Mol. Neurosci. 2013, 6:36.
3. Alves R., Antunes F., Salvador A. Tools for kinetic modeling of biochemical networks. Nat. Biotechnol. 2006, 24:667-672.
4. Aqdam M.J., Kamali K., Rahgozar M., Ohadi M., Manoochehri M., Tahami A., Bostanshirin L., Khorshid H.R. Association of CALHM1 gene polymorphism with late onset Alzheimer's disease in Iranian population. Avicenna J. Med. Biotechnol. 2010, 2:153-157.
5. Area-Gomez E., de Groof A.J., Boldogh I., Bird T.D., Gibson G.E., Koehler C.M., Yu W.H., Duff K.E., Yaffe M.P., Pon L.A., Schon E.A. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am. J. Pathol. 2009, 175:1810-1816.
6. Area-Gomez E., Del Carmen Lara Castillo M., Tambini M.D., Guardia-Laguarta C., de Groof A.J., Madra M., Ikenouchi J., Umeda M., Bird T.D., Sturley S.L., Schon E.A. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 2012, 31:4106-4123.
7. Arendt T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 2009, 118:167-179.
8. Augustine G.J. How does calcium trigger neurotransmitter release?. Curr. Opin. Neurobiol. 2001, 11:320-326.
9. Bandara S., Malmersjo S., Meyer T. Regulators of calcium homeostasis identified by inference of kinetic model parameters from live single cells perturbed by siRNA. Sci. Signal. 2013, 6:ra56.
10. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science (New York, NY) 1982, 217:408-414.
11. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics: homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
12. Berridge M.J. Elementary and global aspects of calcium signalling. J. Physiol. 1997, 499(Pt 2):291-306.
13. Berridge M.J. Calcium hypothesis of Alzheimer's disease. Eur. J. Physiol. 2010, 459:441-449.
14. Berridge M.J. Calcium regulation of neural rhythms, memory and Alzheimer's disease. J. Physiol. 2014, 592:281-293.
15. 3) receptor functional properties. Cell Calcium 1994, 16:151-166.
16. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 2005, 38:261-272.
17. Bezprozvanny I. Presenilins and calcium signaling-systems biology to the rescue. Sci. Signal. 2013, 6:pe24.
18. Blackwell K.T., Kotaleski J. Modeling the dynamics of second messenger pathways. Neuroscience Databases 2003, 63-79. Springer, US. R. Kötter (Ed.).
19. Blackwell K.T. Approaches and tools for modeling signaling pathways and calcium dynamics in neurons. J. Neurosci. Methods 2013, 220:131-140.
20. Boada M., Antunez C., Lopez-Arrieta J., Galan J.J., Moron F.J., Hernandez I., Marin J., Martinez-Lage P., Alegret M., Carrasco J.M., Moreno C., Real L.M., Gonzalez-Perez A., Tarraga L., Ruiz A. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. J. Alzheimers Dis. 2010, 20:247-251.
21. Bojarski L., Herms J., Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 2008, 52:621-633.
22. 2+ entry in familial Alzheimer's disease. Biochim. Biophys. Acta 2009, 1793:1050-1057.
23. Bondarenko V.E., Szigeti G.P., Bett G.C., Kim S.J., Rasmusson R.L. Computer model of action potential of mouse ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1378-H1403.
24. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
25. Brette R., Rudolph M., Carnevale T., Hines M., Beeman D., Bower J.M., Diesmann M., Morrison A., Goodman P.H., Harris F.C., Zirpe M., Natschlager T., Pecevski D., Ermentrout B., Djurfeldt M., Lansner A., Rochel O., Vieville T., Muller E., Davison A.P., El Boustani S., Destexhe A. Simulation of networks of spiking neurons: a review of tools and strategies. J. Comput. Neurosci. 2007, 23:349-398.
26. 2+ uptake. J. Cell Mol. Med. 2009, 13:3358-3369.
27. Brunkan A.L., Goate A.M. Presenilin function and γ-secretase activity. J. Neurochem. 2005, 93:769-792.
28. Bruno A.M., Huang J.Y., Bennett D.A., Marr R.A., Hastings M.L., Stutzmann G.E. Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2012, 33:1001.e1001-1001.e1006.
29. Buchholz J.N., Pottorf J.N., Vanterpool C.K., Behringer E.J., Duckles S.P. Calcium regulation in neuronal function with advancing age: limits of homeostasis. Senescence 2012, 531-558. InTech. T. Nagata (Ed.).
30. Buxbaum J.D., Ruefli A.A., Parker C.A., Cypess A.M., Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4489-4493.
31. Casley C.S., Lakics V., Lee H.G., Broad L.M., Day T.A., Cluett T., Smith M.A., O'Neill M.J., Kingston A.E. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-beta peptide. Brain Res. 2009, 1260:65-75.
32. 2+ channel function as an early preventative strategy for Alzheimer's disease. PLoS One 2012, 7:e52056.
33. Chakroborty S., Kim J., Schneider C., Jacobson C., Molgó J., Stutzmann G.E. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J. Neurosci. 2012, 32:8341-8353.
34. Chan S.L., Mayne M., Holden C.P., Geiger J.D., Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 2000, 275:18195-18200.
35. 3 receptor channel gating. Neuron 2008, 58:871-883.
36. Cheung K.H., Mei L., Mak D.O., Hayashi I., Iwatsubo T., Kang D.E., Foskett J.K. Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons. Sci. Signal. 2010, 3:ra22.
37. Chivet M., Hemming F., Pernet-Gallay K., Fraboulet S., Sadoul R. Emerging role of neuronal exosomes in the central nervous system. Front. Physiol. 2012, 3:145.
38. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 2000, 71:621s-629s.
39. Christensen R.A., Shtifman A., Allen P.D., Lopez J.R., Querfurth H.W. Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes. J. Biol. Chem. 2004, 279:53524-53532.
40. Corona C., Pensalfini A., Frazzini V., Sensi S.L. New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis. 2011, 2:e176.
41. Costa R.O., Lacor P.N., Ferreira I.L., Resende R., Auberson Y.P., Klein W.L., Oliveira C.R., Rego A.C., Pereira C.M.F. Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers. Aging Cell 2012, 11:823-833.
42. Cowburn R.F., Wiehager B., Sundström E. β-amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(1,4,5)trisphosphate and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes. Neurosci. Lett. 1995, 191:31-34.
43. Craig L.A., Hong N.S., McDonald R.J. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosc. Biobehav. Rev. 2011, 35:1397-1409.
44. Cruts M., Theuns J., Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 2012, 33:1340-1344.
45. Cui P.J., Zheng L., Cao L., Wang Y., Deng Y.L., Wang G., Xu W., Tang H.D., Ma J.F., Zhang T., Ding J.Q., Cheng Q., Chen S.D. CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population. J. Alzheimers Dis.: JAD 2010, 19:31-35.
46. de Schutter E., Smolen P. Calcium dynamics in large neuronal models. Methods in Neuronal Modeling 1998, 211-250. MIT Press. 2nd ed. C. Koch, I. Segev (Eds.).
47. 2+ release from intracellular stores. Biochem. J. 2003, 370:621-629.
48. 2+. J. Theor. Biol. 2013, 331:12-18.
49. De Strooper B., Iwatsubo T., Wolfe M.S. Presenilins and gamma-secretase: structure, function, and role in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006304.
50. 2+ concentration. Proc. Natl. Acad. Sci. 1992, 89:9895-9899.
51. 2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate. J. Neurosci.: Off. J. Soc. Neurosci. 2013, 33:3824-3833.
52. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 2005, 280:17294-17300.
53. Diederichs F. Ion homeostasis and the functional roles of SERCA reactions in stimulus-secretion coupling of the pancreatic beta-cell: a mathematical simulation. Biophys. Chem. 2008, 134:119-143.
54. 2+ threshold dynamics detect spike timing in cerebellar Purkinje cells. J. Neurosci.: Off. J. Soc. Neurosci. 2005, 25:950-961.
55. 2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 2008, 133:1149-1161.
56. Elbaz Y., Schuldiner M. Staying in touch: the molecular era of organelle contact sites. Trends Biochem. Sci. 2011, 36:616-623.
57. Emilsson L., Saetre P., Jazin E. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol. Dis. 2006, 21:618-625.
58. Ermak G., Davies K.J.A. Calcium and oxidative stress: from cell signaling to cell death. Mol. Immunol. 2002, 38:713-721.
59. Ferreira I.L., Bajouco L.M., Mota S.I., Auberson Y.P., Oliveira C.R., Rego A.C. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 2012, 51:95-106.
60. Ferreira S.T., Clarke J.R., Bomfim T.R., De Felice F.G. Inflammation defective insulin signaling, and neuronal dysfunction in Alzheimer's disease. Alzheimers Demen. 2014, 10:S76-S83.
61. 2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J. Neurosci. Res. 2004, 76:872-880.
62. Ferreiro E., Resende R., Costa R., Oliveira C.R., Pereira C.M.F. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol. Dis. 2006, 23:669-678.
63. Fink C.C., Slepchenko B., Moraru I.I., Watras J., Schaff J.C., Loew L.M. An image-based model of calcium waves in differentiated neuroblastoma cells. Biophys. J. 2000, 79:163-183.
64. Floyd R.A., Hensley K. Oxidative stress in brain aging: implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 2002, 23:795-807.
65. 2+ release channels. Physiol. Rev. 2007, 87:593-658.
66. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66:137-147.
67. Galeotti N., Vivoli E., Bartolini A., Ghelardini C. A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. J. Neurochem. 2008, 106:2385-2394.
68. Gallego-Sandin S., Alonso M.T., Garcia-Sancho J. Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress. Biochem. J. 2011, 437:469-475.
69. Ghidoni R., Paterlini A., Albertini V., Glionna M., Monti E., Schiaffonati L., Benussi L., Levy E., Binetti G. Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiol. Aging 2011, 32:1435-1442.
70. 2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol. Dis. 2005, 18:638-648.
71. Gin E., Kirk V., Sneyd J. A bifurcation analysis of calcium buffering. J. Theor. Biol. 2006, 242:1-15.
72. 2+ oscillations and for their frequency encoding through protein phosphorylation. Proc. Natl. Acad. Sci. 1990, 87:1461-1465.
73. 2+ and excitability in a modeled neuron. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:15130-15135.
74. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 2000, 156:15-20.
75. Goussakov I., Miller M.B., Stutzmann G.E. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. J. Neurosci.: Off. J. Soc. Neurosci. 2010, 30:12128-12137.
76. Green K.N., Demuro A., Akbari Y., Hitt B.D., Smith I.F., Parker I., LaFerla F.M. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J. Cell Biol. 2008, 181:1107-1116.
77. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci.: Off. J. Soc. Neurosci. 1997, 17:4212-4222.
78. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 1999, 5:101-106.
79. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science (New York, N.Y.) 1992, 256:184-185.
80. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (New York, N.Y.) 2002, 297:353-356.
81. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
82. Hayashi T., Rizzuto R., Hajnoczky G., Su T.P. MAM: more than just a housekeeper. Trends Cell. Biol. 2009, 19:81-88.
83. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
84. Hedskog L., Pinho C.M., Filadi R., Ronnback A., Hertwig L., Wiehager B., Larssen P., Gellhaar S., Sandebring A., Westerlund M., Graff C., Winblad B., Galter D., Behbahani H., Pizzo P., Glaser E., Ankarcrona M. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:7916-7921.
85. Herms J., Schneider I., Dewachter I., Caluwaerts N., Kretzschmar H., Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J. Biol. Chem. 2003, 278:2484-2489.
86. 2+ release in muscle and neurons. Biol. Res. 2004, 37:539-552.
87. Higgins E.R., Cannell M.B., Sneyd J. A buffering SERCA pump in models of calcium dynamics. Biophys. J. 2006, 91:151-163.
88. Holcman D., Schuss Z., Korkotian E. Calcium dynamics in dendritic spines and spine motility. Biophys. J. 2004, 87:81-91.
89. Holmes W.R., Levy W.B. Insights into associative long-term potentiation from computational models of NMDA receptor-mediated calcium influx and intracellular calcium concentration changes. J. Neurophysiol. 1990, 63:1148-1168.
90. Iqbal K., del C., Alonso A., Chen S., Chohan M.O., El-Akkad E., Gong C.-X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta, Mol. Basis Dis. 2005, 1739:198-210.
91. Isaacs A.M., Senn D.B., Yuan M., Shine J.P., Yankner B.A. Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium. J. Biol. Chem. 2006, 281:27916-27923.
92. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl. Acad. Sci. 1994, 91:534-538.
93. 3 receptor-dependent calcium signaling. J. Gen. Physiol. 1997, 110:529-538.
94. Karran E., Mercken M., Strooper B.D. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 2011, 10:698-712.
95. 2+ content in presenilin double knock-out cells. Cell Calcium 2006, 40:41-51.
96. Kawahara M., Ohtsuka I., Yokoyama S., Kato-Negishi M., Sadakane Y. Membrane incorporation channel formation, and disruption of calcium homeostasis by Alzheimer's β-amyloid protein. Int. J. Alzheimers Dis. 2011, 2011:304583.
97. 2+ oscillations. Biophys. J. 1996, 71:3477-3487.
98. Kelliher M., Fastbom J., Cowburn R.F., Bonkale W., Ohm T.G., Ravid R., Sorrentino V., O'Neill C. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience 1999, 92:499-513.
99. Kelly B.L., Ferreira A. beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-d-aspartate receptors in hippocampal neurons. J. Biol. Chem. 2006, 281:28079-28089.
100. Khachaturian Z.S. Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol. Aging 1987, 8:345-346.
101. Khachaturian Z.S. Calcium hypothesis of Alzheimer's disease and brain aging. Ann. N.Y. Acad. Sci. 1994, 747:1-11.
102. + currents of Drosophila larval cholinergic neurons: modeled actions on firing properties. Invert. Neurosci. 2006, 6:207-213.
103. Koppel J., Campagne F., Vingtdeux V., Dreses-Werringloer U., Ewers M., Rujescu D., Hampel H., Gordon M.L., Christen E., Chapuis J., Greenwald B.S., Davies P., Marambaud P. CALHM1 P86L polymorphism modulates CSF Abeta levels in cognitively healthy individuals at risk for Alzheimer's disease. Mol. Med. (Cambridge Mass.) 2011, 17:974-979.
104. Koran M.E., Hohman T.J., Thornton-Wells T.A. Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography. Hum. Genet. 2014, 133:85-93.
105. Kuchibhotla K.V., Goldman S.T., Lattarulo C.R., Wu H.-Y., Hyman B.T., Bacskai B.J. Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008, 59:214-225.
106. Kurumatani T., Fastbom J., Bonkale W.L., Bogdanovic N., Winblad B., Ohm T.G., Cowburn R.F. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology. Brain Res. 1998, 796:209-221.
107. Lambert J.C., Sleegers K., Gonzalez-Perez A., Ingelsson M., Beecham G.W., Hiltunen M., Combarros O., Bullido M.J., Brouwers N., Bettens K., Berr C., Pasquier F., Richard F., Dekosky S.T., Hannequin D., Haines J.L., Tognoni G., Fievet N., Dartigues J.F., Tzourio C., Engelborghs S., Arosio B., Coto E., De Deyn P., Del Zompo M., Mateo I., Boada M., Antunez C., Lopez-Arrieta J., Epelbaum J., Schjeide B.M., Frank-Garcia A., Giedraitis V., Helisalmi S., Porcellini E., Pilotto A., Forti P., Ferri R., Delepine M., Zelenika D., Lathrop M., Scarpini E., Siciliano G., Solfrizzi V., Sorbi S., Spalletta G., Ravaglia G., Valdivieso F., Vepsalainen S., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Hanon O., Piccardi P., Annoni G., Mann D., Marambaud P., Seripa D., Galimberti D., Tanzi R.E., Bertram L., Lendon C., Lannfelt L., Licastro F., Campion D., Pericak-Vance M.A., Soininen H., Van Broeckhoven C., Alperovitch A., Ruiz A., Kamboh M.I., Amouyel P. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J. Alzheimers Dis.: JAD 2010, 22:247-255.
108. LeBeau A.P., Yule D.I., Groblewski G.E., Sneyd J. Agonist-dependent phosphorylation of the inositol 1,4,5-trisphosphate receptor: a possible mechanism for agonist-specific calcium oscillations in pancreatic acinar cells. J. Gen. Physiol. 1999, 113:851-872.
109. Lee S.Y., Hwang D.Y., Kim Y.K., Lee J.W., Shin I.C., Oh K.W., Lee M.K., Lim J.S., Yoon D.Y., Hwang S.J., Hong J.T. PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. FASEB J. 2006, 20:151-153.
110. Leissring M.A., Paul B.A., Parker I., Cotman C.W., LaFerla F.M. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J. Neurochem. 1999, 72:1061-1068.
111. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 2000, 149:793-798.
112. i oscillations derived from a detailed kinetic model: a Hodgkin-Huxley like formalism. J. Theor. Biol. 1994, 166:461-473.
113. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
114. Li X., Dang S., Yan C., Gong X., Wang J., Shi Y. Structure of a presenilin family intramembrane aspartate protease. Nature 2013, 493:56-61.
115. 2+] in adult Alzheimer's disease mice. J. Neurochem. 2008, 105:262-271.
116. Müller M., Cheung K.-H., Foskett J.K. Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP(3)R Ca(2+) signaling. Antioxid. Redox Signal. 2011, 14:1225-1235.
117. Maes O.C., Chertkow H.M., Wang E., Schipper H.M. MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr. Genomics 2009, 10:154-168.
118. 3 receptors. J. Gen. Physiol. 2001, 117:435-446.
119. Manjarres I.M., Rodriguez-Garcia A., Alonso M.T., Garcia-Sancho J. The sarco/endoplasmic reticulum Ca(2+) ATPase (SERCA) is the third element in capacitative calcium entry. Cell Calcium 2010, 47:412-418.
120. Matsuoka S., Sarai N., Kuratomi S., Ono K., Noma A. Role of individual ionic current systems in ventricular cells hypothesized by a model study. Jpn. J. Physiol. 2003, 53:105-123.
121. Mattson M.P., Zhu H., Yu J., Kindy M.S. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci.: Off. J. Soc. Neurosci. 2000, 20:1358-1364.
122. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2000, 23:222-229.
123. Minster R.L., Demirci F.Y., DeKosky S.T., Kamboh M.I. No association between CALHM1 variation and risk of Alzheimer disease. Hum. Mutat. 2009, 30:E566-E569.
124. Mohamed A., Posse de Chaves E. Aβ internalization by neurons and glia. Int. J. Alzheimers Dis. 2011, 2011:127984.
125. Morse T.M., Carnevale N.T., Mutalik P.G., Migliore M., Shepherd G.M. Abnormal excitability of oblique dendrites implicated in early Alzheimer's: a computational study. Front. Neural Circuits 2010, 4:16.
126. Nakano T., Yoshimoto J., Doya K. A model-based prediction of the calcium responses in the striatal synaptic spines depending on the timing of cortical and dopaminergic inputs and post-synaptic spikes. Front. Comput. Neurosci. 2013, 7:119.
127. Nelson O., Supnet C., Tolia A., Horre K., De Strooper B., Bezprozvanny I. Mutagenesis mapping of the presenilin 1 calcium leak conductance pore. J. Biol. Chem. 2011, 286:22339-22347.
128. Oddo S., Caccamo A., Smith I.F., Green K.N., LaFerla F.M. A dynamic relationship between intracellular and extracellular pools of Abeta. Am. J. Pathol. 2006, 168:184-194.
129. Oule's B., Del Prete D., Greco B., Zhang X., Lauritzen I., Sevalle J., Moreno S., Paterlini-Brechot P., Trebak M., Checler F., Benfenati F., Chami M. Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J. Neurosci.: Off. J. Soc. Neurosc. 2012, 32:11820-11834.
130. Palop J.J., Mucke L. Amyloid-β induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
131. Pasti L., Volterra A., Pozzan T., Carmignoto G. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J. Neurosci. 1997, 17:7817-7830.
132. Pierrot N., Ghisdal P., Caumont A.-S., Octave J.-N. Intraneuronal amyloid-β1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J. Neurochem. 2004, 88:1140-1150.
133. Querfurth H.W., Selkoe D.J. Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 1994, 33:4550-4561.
134. Querfurth H.W., Jiang J., Geiger J.D., Selkoe D.J. Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. J. Neurochem. 1997, 69:1580-1591.
135. 3. Channels 2009, 3:226-232.
136. Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., Simons K. Alzheimer's disease β-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11172-11177.
137. Renner M., Lacor P.N., Velasco P.T., Xu J., Contractor A., Klein W.L., Triller A. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 2010, 66:739-754.
138. 2+ oscillations in astrocytes: particulars of Alzheimer's disease. Biophys. J. 2011, 101:554-564.
139. Rowland A.A., Voeltz G.K. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat. Rev. Mol. Cell Biol. 2012, 13:607-625.
140. Rubin J.E., Gerkin R.C., Bi G.Q., Chow C.C. Calcium time course as a signal for spike-timing-dependent plasticity. J. Neurophysiol. 2005, 93:2600-2613.
141. Ryan K.A., Pimplikar S.W. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 2005, 171:327-335.
142. Rybalchenko V., Hwang S.Y., Rybalchenko N., Koulen P. The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int. J. Biochem. Cell Biol. 2008, 40:84-97.
143. 2+ release channel adaptation. Science (New York, N.Y.) 1995, 267:2010-2011.
144. Saftenku E., Williams A.J., Sitsapesan R. Markovian models of low and high activity levels of cardiac ryanodine receptors. Biophys. J. 2001, 80:2727-2741.
145. Sanz-Arigita E.J., Schoonheim M.M., Damoiseaux J.S., Rombouts S.A., Maris E., Barkhof F., Scheltens P., Stam C.J. Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One 2010, 5:e13788.
146. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher R.J., Kandel E.R., Duff K., Kirkwood A., Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004, 42:23-36.
147. Schapansky J., Olson K., Van Der Ploeg R., Glazner G. NF-κB activated by ER calcium release inhibits Aβ-mediated expression of CHOP protein: enhancement by AD-linked mutant presenilin 1. Exp. Neurol. 2007, 208:169-176.
148. 2+ dynamics in dendritic spines. J. Neurophysiol. 1995, 74:1046-1055.
149. Schon E.A., Area-Gomez E. Mitochondria-associated ER membranes in Alzheimer disease. Mol. Cell. Neurosci. 2013, 55:26-36.
150. Schuster S., Marhl M., Hofer T. Modelling of simple and complex calcium oscillations. From single-cell responses to intercellular signalling. Eur. J. Biochem. FEBS 2002, 269:1333-1355.
151. Shen J., Kelleher R.J. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:403-409.
152. 2+ leak channels. J. Biol. Chem. 2012, 287:10933-10944.
153. 2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis. J. Neurosci. 2014, 34:6910-6923.
154. 2+ release and contractility in skeletal muscle. Neurobiol. Aging 2010, 31:2080-2090.
155. Smith I.F., Green K.N., LaFerla F.M. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 2005, 38:427-437.
156. Sneyd J., Falcke M. Models of the inositol trisphosphate receptor. Prog. Biophys. Mol. Biol. 2005, 89:207-245.
157. Sneyd J., Girard S., Clapham D. Calcium wave propagation by calcium-induced calcium release: an unusual excitable system. Bull. Math. Biol. 1993, 55:315-344.
158. Soboloff J., Rothberg B.S., Madesh M., Gill D.L. STIM proteins: dynamic calcium signal transducers. Nat. Rev. Mol. Cell Biol. 2012, 13:549-565.
159. Sterratt D., Graham B., Gillies A., Willshaw D. Intracellular mechanisms. Principles of Computational Modelling in Neuroscience 2011, Cambridge University Press.
160. Stutzmann G.E., Mattson M.P. Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol. Rev. 2011, 63:700-727.
161. 2+ signals and altered membrane excitability. J. Neurosc.: Off. J. Soc. Neurosci. 2004, 24:508-513.
162. 2+ disruptions in young adult, and aged Alzheimer's disease mice. J. Neurosci.: Off. J. Soc. Neurosci. 2006, 26:5180-5189.
163. Stutzmann G.E., Smith I., Caccamo A., Oddo S., Parker I., Laferla F. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models. Ann. N.Y. Acad. Sci. 2007, 1097:265-277.
164. Sun S., Zhang H., Liu J., Popugaeva E., Xu N.J., Feske S., White C.L., Bezprozvanny I. Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice. Neuron 2014, 82:79-93.
165. Supekar K., Menon V., Rubin D., Musen M., Greicius M.D. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput. Biol. 2008, 4:e1000100.
166. Supnet C., Bezprozvanny I. The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 2010, 47:183-189.
167. Supnet C., Bezprozvanny I. Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Cell Calcium 2011, 50:303-309.
168. Supnet C., Grant J., Kong H., Westaway D., Mayne M. Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice. J. Biol. Chem. 2006, 281:38440-38447.
169. Supnet C., Noonan C., Richard K., Bradley J., Mayne M. Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer's disease. J. Neurochem. 2010, 112:356-365.
170. Tan E.K., Ho P., Cheng S.Y., Yih Y., Li H.H., Fook-Chong S., Lee W.L., Zhao Y. CALHM1 variant is not associated with Alzheimer's disease among Asians. Neurobiol. Aging 2011, 32:546.e511-546.e512.
171. 2+. Nature 2009, 458:655-659.
172. Thibault O., Gant J.C., Landfield P.W. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007, 6:307-317.
173. Thies W., Bleiler L. Alzheimer's disease facts and figures. Alzheimers Dement.: J. Alzheimers Assoc. 2013, 9:208-245.
174. Tiveci S., Akin A., Cakir T., Saybasili H., Ulgen K. Modelling of calcium dynamics in brain energy metabolism and Alzheimer's disease. Comput. Biol. Chem. 2005, 29:151-162.
175. Toivari E., Manninen T., Nahata A.K., Jalonen T.O., Linne M.L. Effects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: fura-2AM measurements and stochastic model simulations. PLoS One 2011, 6:e17914.
176. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006, 126:981-993.
177. Um J.W., Kaufman A.C., Kostylev M., Heiss J.K., Stagi M., Takahashi H., Kerrisk M.E., Vortmeyer A., Wisniewski T., Koleske A.J., Gunther E.C., Nygaard H.B., Strittmatter S.M. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 2013, 79:887-902.
178. Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7:65-74.
179. Van den Hove D.L., Kompotis K., Lardenoije R., Kenis G., Mill J., Steinbusch H.W., Lesch K.-P., Fitzsimons C.P., De Strooper B., Rutten B.P.F. Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiol. Aging 2014, 35:731-745.
180. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 2005, 85:201-279.
181. Volfovsky N., Parnas H., Segal M., Korkotian E. Geometry of dendritic spines affects calcium dynamics in hippocampal neurons: theory and experiments. J. Neurophysiol. 1999, 82:450-462.
182. Wang S.S.S., Kazantzi V., Good T.A. A kinetic analysis of the mechanism of β-amyloid induced G protein activation. J. Theor. Biol. 2003, 221:269-278.
183. Wilson N.P., Gates B., Castellanos M. Modeling the short time-scale dynamics of β-amyloid-neuron interactions. J. Theor. Biol. 2013, 331:28-37.
184. Wischik C.M., Wischik D.J., Storey J.M.D., Harrington C.R. Rationale for tau-aggregation inhibitor therapy in Alzheimer's disease and other tauopathies. Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism 2010, 210-232. The Royal Society of Chemistry, (chapter 11).
185. Wu B., Yamaguchi H., Lai F.A., Shen J. Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:15091-15096.
186. Wuytack F., Raeymaekers L., Missiaen L. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 2002, 32:279-305.
187. 2+ oscillations. Biochem. J. 2004, 383:353-360.
188. Young J.E., Goldstein L.S.B. Alzheimer's disease in a dish: promises and challenges of human stem cell models. Hum. Mol. Genet. 2012, 21:R82-R89.
189. 2+ cross-talk. Proc. Natl. Acad. Sci. 2011, 108:2777-2782.
190. 2+ channels reduces Alzheimer disease beta-amyloid peptide secretion. J. Biol. Chem. 2013, 288:26955-26966.
191. Zhang H., Sun S., Herreman A., De Strooper B., Bezprozvanny I. Role of presenilins in neuronal calcium homeostasis. J. Neurosc.: Off. J. Soc. Neurosc. 2010, 30:8566-8580.